Get Cash Back and $0 Commissions + The Power of TradeStation
Consolidated Research: 2018 Summary Expectations for CarGurus, ARMOUR Residential REIT, Braskem S.A, HCI Group, Kimball Electronics, and CytomX Therapeutics Fundamental Analysis, Key Performance Indications
Globe Newswire 27-Nov-2018 8:10 AM
NEW YORK, Nov. 27, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CarGurus, Inc. (NASDAQ:CARG), ARMOUR Residential REIT, Inc. (NYSE:ARR), Braskem S.A. (NYSE:BAK), HCI Group, Inc. (NYSE:HCI), Kimball Electronics, Inc. (NASDAQ:KE), and CytomX Therapeutics, Inc. (NASDAQ:CTMX), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine CarGurus, Inc. (NASDAQ:CARG), ARMOUR Residential REIT, Inc. (NYSE:ARR), Braskem S.A. (NYSE:BAK), HCI Group, Inc. (NYSE:HCI), Kimball Electronics, Inc. (NASDAQ:KE), and CytomX Therapeutics, Inc. (NASDAQ:CTMX) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed November 23rd, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
CARGURUS, INC. (CARG) REPORT OVERVIEW
CarGurus' Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, CarGurus reported revenue of $119.04MM vs $82.99MM (up 43.44%) and analysts estimated basic earnings per share $0.11 vs $0.02 (up 450.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, CarGurus reported revenue of $316.86MM vs $198.14MM (up 59.92%) and analysts estimated basic earnings per share $0.13 vs -$0.58. Analysts expect earnings to be released on March 7th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.02. The estimated EPS forecast for the next fiscal year is $0.19 and is expected to report on March 7th, 2019.
For the three months ended September 30th, 2018 vs September 30th, 2017, ARMOUR Residential REIT reported revenue of $72.63MM vs $66.78MM (up 8.76%) and analysts estimated basic earnings per share $1.03 vs $0.58 (up 77.59%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, ARMOUR Residential REIT reported revenue of $254.43MM vs $264.00MM (down 3.62%) and analysts estimated basic earnings per share $4.22 vs -$1.67. Analysts expect earnings to be released on February 13th, 2019. The report will be for the fiscal period ending December 31st, 2018. The estimated EPS forecast for the next fiscal year is $2.51 and is expected to report on February 13th, 2019.
For the three months ended September 30th, 2018 vs September 30th, 2017, Braskem S.A reported revenue of $4,152.43MM vs $3,846.86MM (up 7.94%) and analysts estimated basic earnings per share $0.86 vs $0.64 (up 35.12%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Braskem S.A reported revenue of $15,428.42MM vs $13,665.27MM (up 12.90%) and analysts estimated basic earnings per share $3.21 vs -$0.52. Analysts expect earnings to be released on April 4th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $0.30. The estimated EPS forecast for the next fiscal year is $2.25 and is expected to report on April 4th, 2019.
For the three months ended September 30th, 2018 vs September 30th, 2017, HCI Group reported revenue of $61.74MM vs $47.49MM (up 30.01%) and basic earnings per share $1.08 vs -$4.44. For the twelve months ended December 31st, 2017 vs December 31st, 2016, HCI Group reported revenue of $244.41MM vs $264.45MM (down 7.58%) and analysts estimated basic earnings per share -$0.75 vs $2.95. Analysts expect earnings to be released on March 5th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $1.14. The estimated EPS forecast for the next fiscal year is $4.50 and is expected to report on March 5th, 2019.
For the three months ended September 30th, 2018 vs September 30th, 2017, Kimball Electronics reported revenue of $265.62MM vs $253.20MM (up 4.90%) and analysts estimated basic earnings per share $0.19 vs $0.32 (down 40.63%). For the twelve months ended June 30th, 2018 vs June 30th, 2017, Kimball Electronics reported revenue of $1,072.06MM vs $930.91MM (up 15.16%) and analysts estimated basic earnings per share $0.63 vs $1.25 (down 49.60%). Analysts expect earnings to be released on February 6th, 2019. The report will be for the fiscal period ending December 31st, 2018.
For the three months ended September 30th, 2018 vs September 30th, 2017, CytomX Therapeutics reported revenue of $12.51MM vs $24.14MM (down 48.19%) and analysts estimated basic earnings per share -$0.53 vs -$0.28. For the twelve months ended December 31st, 2017 vs December 31st, 2016, CytomX Therapeutics reported revenue of $71.62MM vs $15.04MM (up 376.12%) and analysts estimated basic earnings per share -$1.16 vs -$1.63. Analysts expect earnings to be released on March 6th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.02. The estimated EPS forecast for the next fiscal year is -$2.14 and is expected to report on March 6th, 2019.
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
